Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phage therapy for prevention of ventilator-associated bacterial pneumonia in PICU patients
IRCT20230701058628N1Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Jun 2021
- Countries
- 1
01
Overview
Phase 3 trial of bacteriophages in ventilator-associated pneumonia (VAP) and bacterial pneumonia, sponsored by Mazandaran University of Medical Sciences. Started Jun 2021; status: completed.
02
Drugs
bacteriophages
03
Conditions
ventilator-associated pneumonia (VAP)bacterial pneumonia
Beyond the preview
Go deeper on IRCT20230701058628N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230701058628N1.